Patient stratification by genetic risk in Alzheimer's disease is only effective in the presence of phenotypic heterogeneity.
Case-only designs in longitudinal cohorts are a valuable resource for identifying disease-relevant genes, pathways, and novel targets influencing disease progression. This is particularly relevant in Alzheimer's disease (AD), where longitudinal cohorts measure disease "progression," d...
Saved in:
Main Authors: | Jack Euesden, Muhammad Ali, Chloe Robins, Praveen Surendran, Padhraig Gormley, Alzheimer’s Disease Neuroimaging Initiative (ADNI), David Pulford, Carlos Cruchaga |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0310977 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Applications of Neuroimaging to Disease-Modification Trials in Alzheimer’s Disease
by: Adam S. Fleisher, et al.
Published: (2009-01-01) -
APOE4 and infectious diseases jointly contribute to brain glucose hypometabolism, a biomarker of Alzheimer's pathology: New findings from the ADNI.
by: Aravind Lathika Rajendrakumar, et al.
Published: (2025-01-01) -
APOE4 and infectious diseases jointly contribute to brain glucose hypometabolism, a biomarker of Alzheimer’s pathology: New findings from the ADNI
by: Aravind Lathika Rajendrakumar, et al.
Published: (2025-01-01) -
Benchmarking Alzheimer’s disease prediction: personalised risk assessment using polygenic risk scores across various methodologies and genome-wide studies
by: Eftychia Bellou, et al.
Published: (2025-01-01) -
MIAU: An analysis-ready dataset on presence-only and presence-absence data of Neotropical carnivores (Mammalia, Carnivora) from 2000 to 2021
by: Florencia Grattarola, et al.
Published: (2025-01-01)